Interactions between collagen IV and collagen-binding integrins in renal cell repair after sublethal injury.
Recent studies demonstrate that collagen IV selectively promotes the repair of physiological processes in sublethally injured renal proximal tubular cells (RPTC). We sought to further define the mechanisms of cell repair by measuring the effects of toxicant injury and stimulation of repair by L-ascorbic acid-2-phosphate (AscP), exogenous collagen IV, or function-stimulating integrin antibodies on the expression and subcellular localization of collagen-binding integrins (CBI) in RPTC. Expression of CBI subunits alpha1, alpha2, and beta1 in RPTC was not altered on day 1 after sublethal injury by S-(1,2-dichlorovinyl)-L-cysteine (DCVC). On day 6, expression of alpha1 and beta1 subunits remained unchanged, whereas a 2.2-fold increase in alpha2 expression was evident in injured RPTC. CBI localization in control RPTC was limited exclusively to the basal membrane. On day 1 after injury, RPTC exhibited a marked inhibition of active Na(+) transport and a loss of cell polarity characterized by a decrease in basal CBI localization and the appearance of CBI on the apical membrane. On day 6 after injury, RPTC still exhibited marked inhibition of active Na(+) transport and localization of CBI to the apical membrane. However, DCVC-injured RPTC cultured in pharmacological concentrations of AscP (500 microM) or exogenous collagen IV (50 microg/ml) exhibited an increase in active Na(+) transport, relocalization of CBI to the basal membrane, and the disappearance of CBI from the apical membrane on day 6. Function-stimulating antibodies to CBI beta1 did not promote basal relocalization of CBI despite stimulating the repair of Na(+)/K(+)-ATPase activity on day 6 after injury. These data demonstrate that DCVC disrupts integrin localization and that physiological repair stimulated by AscP or collagen IV is associated with the basal relocalization of CBI in DCVC-injured RPTC. These data also suggest that CBI-mediated repair of physiological functions may occur independently of integrin relocalization.
Nony
P A
PA
Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Schnellmann
R G
RG
D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001205:Ascorbic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D024141:Collagen Type IV / Q000378:metabolism*; D005260:Female; D016023:Integrins / Q000276:immunology / Q000378:metabolism*; D007668:Kidney / Q000293:injuries / Q000378:metabolism* / Q000473:pathology; D007687:Kidney Tubules, Proximal / Q000187:drug effects / Q000378:metabolism; D011817:Rabbits; D038981:Receptors, Collagen; D000254:Sodium-Potassium-Exchanging ATPase / Q000187:drug effects / Q000378:metabolism; D013347:Subcellular Fractions
D000906:Antibodies; D024141:Collagen Type IV; D016023:Integrins; D038981:Receptors, Collagen; C011669:ascorbate-2-phosphate; D000254:Sodium-Potassium-Exchanging ATPase; D001205:Ascorbic Acid